Anti-α synuclein binding molecules

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9580493
SERIAL NO

14128497

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are anti-human α-synuclein-specific binding molecules, e.g., antibodies or antigen-binding fragments, variants or derivatives thereof, as methods related thereto. Further provided are anti-human α-synuclein binding molecules which bind to specific N-terminal and C-terminal epitopes on human α-synuclein. The binding molecules described herein can be used in pharmaceutical and diagnostic compositions for α-synuclein targeted immunotherapy and diagnosis, respectively.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BIOGEN INTERNATIONAL NEUROSCIENCE GMBH;UNIVERSITAT ZURICH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Grimm, Jan Dubendorf, CH 89 567
Hock, Christoph Erlenbach, CH 42 436
Nitsch, Roger Zumikon, CH 65 525
Su, Lihe Reading, US 11 130
Weihofen, Andreas Zurich, CH 10 66
Weinreb, Paul Andover, US 6 27

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 28, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00